Literature DB >> 20643136

NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

Michael Tranter1, Xiaoping Ren, Tiffany Forde, Michael E Wilhide, Jing Chen, Maureen A Sartor, Mario Medvedovic, W Keith Jones.   

Abstract

It has been shown that the transcription factor NF-kappaB is necessary for late phase cardioprotection after ischemic preconditioning (IPC) in the heart, and yet is injurious after ischemia/reperfusion (I/R). However the downstream gene expression programs that underlie the contribution of NF-kappaB to cardioprotection after late IPC are incompletely understood. The objective of this study was to delineate the specific genes that are regulated by NF-kappaB immediately after a late IPC stimulus and validate the methodology for the identification of NF-kappaB-dependent genes that contribute to cardioprotection. A directed microarray analysis identified 238 genes as up or downregulated in an NF-kappaB-dependent manner 3.5h after late IPC. Among these are several genes previously implicated in late IPC. Gene ontological analysis showed that the most significant group of NF-kappaB-dependent genes are heat shock response genes, including the genes encoding Hsp70.1 and Hsp70.3. Though an Hsp70.1/70.3 double knockout failed to exhibit cardioprotection, late IPC was intact in the Hsp70.1 single knockout. After I/R, the Hsp70.1/70.3 double knockout and the Hsp70.1 single knockout had significantly increased and reduced infarct size, respectively. These results delineate the immediate NF-kappaB-dependent transcriptome after late IPC. One of the major categories of NF-kappaB-dependent genes induced by late IPC is the heat shock response. The results of infarct studies confirm that Hsp70.3 is protective after IPC. However, though Hsp70.1 and Hsp70.3 are coordinately regulated, their functions are opposing after I/R injury. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643136      PMCID: PMC3570030          DOI: 10.1016/j.yjmcc.2010.07.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  59 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

Authors:  R N Van Gelder; M E von Zastrow; A Yool; W C Dement; J D Barchas; J H Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 3.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease.

Authors:  I J Benjamin; D R McMillan
Journal:  Circ Res       Date:  1998-07-27       Impact factor: 17.367

4.  The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning.

Authors:  R Bolli; S Manchikalapudi; X L Tang; H Takano; Y Qiu; Y Guo; Q Zhang; A K Jadoon
Journal:  Circ Res       Date:  1997-12       Impact factor: 17.367

5.  Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo.

Authors:  Maria Brown; Michael McGuinness; Terry Wright; Xiaoping Ren; Yang Wang; Gregory P Boivin; Harvey Hahn; Arthur M Feldman; W Keith Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-02-04       Impact factor: 4.733

6.  TNF-alpha is required for late ischemic preconditioning but not for remote preconditioning of trauma.

Authors:  Xiaoping Ren; Yang Wang; W Keith Jones
Journal:  J Surg Res       Date:  2004-09       Impact factor: 2.192

Review 7.  Delayed adaptation of the heart to stress: late preconditioning.

Authors:  Adam B Stein; Xian-Liang Tang; Yiru Guo; Yu-Ting Xuan; Buddhadeb Dawn; Roberto Bolli
Journal:  Stroke       Date:  2004-09-30       Impact factor: 7.914

8.  Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha.

Authors:  Zheqing Cai; Hua Zhong; Marta Bosch-Marce; Karen Fox-Talbot; Lei Wang; Chiming Wei; Michael A Trush; Gregg L Semenza
Journal:  Cardiovasc Res       Date:  2007-10-11       Impact factor: 10.787

9.  The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors.

Authors:  M Ammirante; A Rosati; A Gentilella; M Festa; A Petrella; L Marzullo; M Pascale; M A Belisario; A Leone; M C Turco
Journal:  Oncogene       Date:  2007-09-03       Impact factor: 9.867

10.  Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.

Authors:  Shweta Rane; Minzhen He; Danish Sayed; Himanshu Vashistha; Ashwani Malhotra; Junichi Sadoshima; Dorothy E Vatner; Stephen F Vatner; Maha Abdellatif
Journal:  Circ Res       Date:  2009-03-05       Impact factor: 17.367

View more
  22 in total

1.  Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation.

Authors:  Michael Tranter; Robert N Helsley; Waltke R Paulding; Michael McGuinness; Cole Brokamp; Lauren Haar; Yong Liu; Xiaoping Ren; W Keith Jones
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 2.  Non-coding RNAs turn up the heat: an emerging layer of novel regulators in the mammalian heat shock response.

Authors:  Robert F Place; Emily J Noonan
Journal:  Cell Stress Chaperones       Date:  2013-09-04       Impact factor: 3.667

3.  Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; Pyare Lal Sharma
Journal:  Mol Cell Biochem       Date:  2012-07-19       Impact factor: 3.396

4.  Acute consumption of a high-fat diet prior to ischemia-reperfusion results in cardioprotection through NF-κB-dependent regulation of autophagic pathways.

Authors:  Lauren Haar; Xiaoping Ren; Yong Liu; Sheryl E Koch; Jillian Goines; Michael Tranter; Melinda A Engevik; Michelle Nieman; Jack Rubinstein; W Keith Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

5.  Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy.

Authors:  Nancy M Andersen; Ruhang Tang; Ling Li; Hadi Javan; Xiu Quan Zhang; Craig H Selzman
Journal:  J Surg Res       Date:  2012-03-22       Impact factor: 2.192

6.  Identification of a NF-κB cardioprotective gene program: NF-κB regulation of Hsp70.1 contributes to cardioprotection after permanent coronary occlusion.

Authors:  Michael E Wilhide; Michael Tranter; Xiaoping Ren; Jing Chen; Maureen A Sartor; Mario Medvedovic; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2011-03-23       Impact factor: 5.000

7.  Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.

Authors:  Hadi Javan; Amanda M Szucsik; Ling Li; Christin L Schaaf; Mohamed E Salama; Craig H Selzman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

Review 8.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.

Authors:  Sumanth D Prabhu; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

9.  Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling.

Authors:  Xiu Q Zhang; Ruhang Tang; Ling Li; Amanda Szucsik; Hadi Javan; Noriko Saegusa; Ken W Spitzer; Craig H Selzman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

10.  High mobility group box 1 (HMGB1) mediates high-glucose-induced calcification in vascular smooth muscle cells of saphenous veins.

Authors:  Yongyi Wang; Jianggui Shan; Wengang Yang; Hui Zheng; Song Xue
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.